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Nguyen Thi Phuong Oanha, Rie Okamotoa, Akie Ichimoria,
Kazuhiro Nogawac, Yasushi Suwazonoc and Hideaki NakagawadABSTRACT: The biological half-life of cadmium (Cd) is as long as 10–30 years. Exposure to this element induces renal tubular
dysfunction, which is considered irreversible. β2-microglobulin (β2-MG) is a low-molecular-weight protein, and urinary β2-MG is
one of the most useful and critical indicators for the early detection of renal tubular dysfunction. However, very little research
has been published concerning the long-term observation of Cd-induced adverse health effects. As such, this follow-up study
was conducted for 28years to clarify the relationship between the concentration of Cd and β2-MG in the urine of 28 inhabitants
(14 male and 14 female) living in the Kakehashi River basin, Ishikawa prefecture ( Japan), previously one of the most highly
Cd-polluted regions in this country. All subjects were over 60years old in 2014 and participated in all six health examinations
conducted over 28years (1986–2014). Urine was collected at the appropriate time and kept frozen to analyze urinary Cd and
β2-MG concentrations. The urinary Cd concentration was found to decrease by nearly half between 1986 and 2008 in both male
and female subjects, whereas it increased significantly from 2008 to 2014 in males. In contrast, urinary β2-MG concentrations
tended to increase over the 28-year study period in both sexes. Urinary Cd and β2-MG concentrations in females were
significantly higher than those in males in this Cd-polluted region. Age is more strongly associated with urinary β2-MG
concentration than recent Cd body burden. Copyright © 2016 John Wiley & Sons, Ltd.
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Cadmium (Cd) is a chemical element, similar to zinc and mercury,
found in group IIb of the periodic table. It is found mainly in the
earth’s crust (WHO, 1992) and is used in solar panels and to
produce Cd-based pigments, etc. High Cd concentrations have
been detected in the air, soil, water and food in regions associated
with mining industries (Nordberg et al., 2007, 2008). Long-term
human exposure to Cd via food or drinking water may lead to
adverse health effects with regards to the function of the internal
organs in the human body, such as liver disease, kidney
dysfunction, osteomalacia and osteoporosis (Nordberg et al.,
2007, 2008; WHO, 1992). Cd exposure also causes renal tubular
dysfunction. One of the most typical diseases associated with Cd
poisoning is Itai-itai disease (‘it hurts-it hurts‘ disease). This disease
was recorded in Cd-polluted areas in the 1950s, with up to 124
cases in the 1970s, although the number of patients had dropped
to 66 by 2006 (Nordberg et al., 2007, 2008; WHO, 1992). In 1969,
Itai-itai disease was recognized by the Japanese Ministry of Health
and Welfare as being as a result of chronic Cd poisoning (WHO,
1992).
In previous studies, we analyzed the indicators urinary protein,
urinary glucose, urinary β2-microglobulin (β2-MG), urinary albumin
and urinary N-Acetyl-beta-D-glucosaminidase (Kido et al., 1987,
1988, 1995), whereas in this survey we focus on the relationship
between urinary Cd and β2-MG as β2-MG, a low-molecular-weightJ. Appl. Toxicol. 2016; 36: 1622–1628 Copyright © 2016 Johnprotein, is one of themost useful and critical indicators for the early
detection of renal tubular dysfunction. Urinary β2-MG has also
been used as an index to evaluate the severity of renal tubular
damage in chronic Cd poisoning, with the upper limit being
considered to be 1 000μgg–1 creatinine (Nogawa et al., 1983; Kido
et al., 1987, 1988; Nishijo et al., 2004; Nakagawa et al., 2006; ). These
previous studies showed that urinary Cd concentrations had
decreased significantly over 22 years (1986-2008) whereas urinary
β2-MG concentrations had increased significantly. Furthermore,
once exposed to Cd, it takes around 30 years for the amount ofWiley & Sons, Ltd.
28-year observation of urinary cadmium and β2-microglobulin in JapanCd remaining in the body to decrease by half (Sato et al., 2013),
and irreversible damage has been reported (Kido et al., 1988). As
such, we conducted this study to clarify the relationship between
urinary Cd and β2-MG concentrations after observation for 28 years
and the effects of Cd exposure on the health of residents living in
Cd-contaminated areas by collecting urine samples and analyzing
follow-up data from 1986 to 2014.Materials and methods
Follow-up study
This 28-year follow-up study is one of the most long-term studies
conducted worldwide. It started in 1986, and six follow-ups were
conducted in 1986, 1991, 1999, 2003, 2008 and 2014, respectively
(Kido et al., 1988; Sato et al., 2010; Sato et al., 2013). Urine samples
were collected from residents living in a Cd-polluted region to
analyze the Cd concentration.Study area
Kakehashi River basin in Komatsu City, Ishikawa Prefecture, which
was one of the most heavily Cd-contaminated regions in Japan,
was selected to conduct this follow-up study.Study populations
The target study population comprised 29 inhabitants aged
60 years and over in 2014, all of whom had participated in all six
follow-ups between 1986 and 2014 and were living in the
Kakehashi River basin. The Cd concentration in the urine of one
female subject could not be determined because of an insufficient
volume of urine. As such, the data in this study were based on 28
participants (14 male and 14 female). The oldest participant was
98 years old and the youngest was 60 years old, the mean ages
of the subjects were 75 [±10 standard deviations (SD)] years
(range: 62–98) and 75 (±8 SD) years (range: 60–85) for males and
females, respectively. The mean residence times were 63 (±20
SD) years (range: 32–94) and 56 (±14 SD) years (range: 35–82) for
males and females, respectively. The health conditions of the
subjects, as they reported on the questionnaires, were as follows:
hypertension (8 persons), cardiovascular disease (5 persons),
diabetes mellitus (3 persons) and cancer (5 persons: thyroid,
bladder, stomach and liver, plus a double cancer of colon and
malignant lymphoma).162Sample collection and urine analysis
Spot urine was collected from each participant and transported in
a cool box. Samples were kept frozen (–20 °C) until analysis to
determine urinary Cd and β2-MG concentrations. As in our
previous studies, the Cd concentration was analyzed by flameless
atomic absorption spectrophotometry (Honda et al., 1989),
whereas a radio-immunoassay (RIA) was used to calculate the β2-
MG concentration and Jaffe’s method was used to determine
urinary creatinine (Cr) levels (Bonsnes and Taussky, 1945). A
questionnaire was used to collect basic information from subjects
such as age, gender and period of residence.J. Appl. Toxicol. 2016; 36: 1622–1628 Copyright © 2016 JohnCalculation and statistical analysis
The measured Cd and β2-MG concentrations were expressed as
corrected for Cr (μgg–1 cr) and non-corrected (μg l–1) and
transformed to logarithms. The JMP 9 @ statistical software
package (SAS Institute, Cary, NC, USA) and Excel 2010 (Microsoft,
Redmond, WA, USA) were used to analyze the results. Significant
differences were determined for P≤ 0.05.Ethics in research
The participants in this follow-up study were all volunteers, and all
personal information was kept confidential. This research was
approved by the Kanazawa University bioethics committee
(approval no. 512).Results
The trends in urinary Cd/Cr and non-corrected Cd concentrations
over nearly three decades are illustrated in Table 1, which shows
that urinary Cd/Cr and Cd concentrations in males decreased
significantly from 1986 to 2008, although they increased
significantly from 2008 to 2014. Significant differences were found
between 1986 and 1999, 2003, 2008; between 1991 and 2008; and
between 2008 and 2014 for urinary Cd/Cr. Similarly, significant
differences were found between 1986 and 1999, 2003, 2008,
2014; between 1991 and 2008; between 1999 and 2008; and
between 2008 and 2014 for non-corrected urinary Cd. In females,
the urinary Cd/Cr and non-corrected Cd concentrations decreased
significantly from 1986 to 2008. Significant differences were found
between 1986 and 2008 and between 1991 and 2008 for urinary
Cd/Cr concentrations. Similarly, significant differences were found
between 1986 and 2008, 2014; between 1991 and 2003, 2008,
2014; and between 1999 and 2008 for the non-corrected urinary
Cd concentration. Table 1 also shows that urinary β2-MG/Cr and
non-corrected β2-MG concentrations increased from 1999
onwards in males. In contrast, both these parameters showed an
increasing trend in females.
Table 2 provides a comparison of the two urinary indicators by
gender over a period of almost 30 years. It is clear that urinary
Cd/Cr concentrations were significantly higher in females than in
males from 1991 to 2008, whereas urinary β2-MG/Cr
concentrations were significantly higher in females than in males
between 1991 and 1999.
Table 3 shows a correlation between urinary Cd/Cr and β2-MG/
Cr concentrations by sex for the period 1986 to 2014. It can be seen
that there are no significant correlations between urinary Cd/Cr
and urinary β2-MG/Cr concentrations in males. In contrast,
significant correlations were observed in 1986, 1991 and 2003 for
females.
Table 4 shows the association between urinary Cd/Cr
concentration in both males and females with age and residency
using a multiple regression analysis. It can be seen that there are
no significant associations between urinary Cd/Cr concentration
and age or residency, except for age for the combined data in
2014.
Table 5 shows the association found in this study between
urinary β2-MG/Cr and urinary Cd/Cr concentrations, age and
period of residency for both males and females using multiple
regression analysis. It is clear that there are no significant
associations, except for a significant association with age in 2003
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Table 3. Correlation coefficients between urinary cadmium
(Cd) and β2-microglobulin (β2-MG) concentrations adjusted
for creatinine (Cr) in males and females from 1986 to 2014
Males= 14 Females = 14
r P r P
1986 0.023 0.486 0.558 0.038
1991 0.002 0.993 0.594 0.025
1999 0.439 0.116 0.295 0.305
2003 0.301 0.296 0.671 0.008
2008 0.381 0.178 0.343 0.230
2014 0.327 0.253 0.482 0.081
r, correlation coefficient, P, P-value.
Table 2. Comparison of urinary cadmium (Cd) and β2-microglobulin (β2-MG) concentrations adjusted for creatinine (Cr) in both sexes
(14 males and 14 females) from 1986 to 2014
Year Sex U-Cd/Cr (μgg–1 cr) U-β2-MG/Cr (μgg–1 cr)
GM GSD P GM GSD P
1986 M 5.45 1.38 0.099 67.3 5.64 0.215
F 7.46 1.81 154.7 5.68
1991 M 4.18 1.51 0.009 78.8 2.26 0.026
F 7.29 1.84 227.5 4.23
1999 M 2.75 1.63 0.017 13.6 12.9 0.017
F 4.77 1.90 163.2 13.7
2003 M 2.89 1.94 0.047 122.6 4.48 0.137
F 4.62 1.68 296.3 4.70
2008 M 1.90 2.30 0.021 196.2 4.40 0.063
F 3.68 1.72 760.8 8.50
2014 M 3.65 1.61 0.095 312.7 7.90 0.302
F 4.91 1.35 801.2 13.8
GM, geometric mean, GSD, geometric standard deviation, P, P-value.
28-year observation of urinary cadmium and β2-microglobulin in JapanTable 6 shows the association between urinary β2-MG/Cr
concentrations for the period 1986 to 2014 and urinary Cd/Cr
concentration in 1986 and age using a multiple regression analysis
for both males and females. No significant correlations were found
between urinary β2-MG/Cr concentration from 1986 to 2014 and
urinary Cd/Cr concentration in 1986 for both sexes. In contrast,
significant associations with age were found in 2003, 2008 and
2014 for males and 1999, 2008 and 2014 for females.162Discussion
Table 1 shows that the reduction in urinary Cd/Cr concentration
over 22 years (from 1986 to 2008) corresponds to the biological
half-life of Cd (10–30 years) (Nordberg et al., 1985; Suwazono
et al., 2009). Moreover, the increase observed from 2008 to 2014
could be explained by the impact of the age factor. Considering
the results in Table 4, age affected Cd/Cr concentrations in urine
for both sexes in 2014. In non-Cd-polluted areas, Cd content in
the renal cortex peaked between the ages of 50 to 70 years and
gradually decreased thereafter (Tsuchiya et al., 1976; Nogawa
et al., 1986; Lyon et al., 1999), whereas urinary Cd and β2-MG
increased almost linearly with advancing age (Moriguchi et al.,J. Appl. Toxicol. 2016; 36: 1622–1628 Copyright © 2016 John2005). However, the trend for study subjects living in the former
Cd-polluted area was different from the pattern for people in
the non-polluted area, as urinary Cd decreased from 1986 to
2008, whereas urinary β2-MG exhibited a rising trend except in
1999 (Table 1). Furthermore, age did not affect urinary Cd (except
in 2014), but it was associated with urinary β2-MG in some cases
(Tables 4–6). The previous study reported a high urinary Cd
content in the case of gastric cancer. For example, a 71-year-old
woman experienced more than a 200-fold increase in urinary
Cd (from 6.2 to 1130.6μg l–1) within a single year (Kido et al.,
1989). Once the Cd was absorbed in the human body, it
accumulated in several organs. If the organs were damaged, as
in this case, sometimes increased levels of urinary Cd were seen.
Of the subjects in this study, five were diagnosed with cancer
between 2007 and 2014 (see the section Study Populations under
Materials and Methods for additional health information) and
three of these showed values of over 5μg g–1 cr urinary Cd, which
are considered relatively high. These phenomena might have
affected the increase in urinary Cd between 2008 and 2014. The
subjects may also be consuming Cd-contaminated food and
water (Kobayashi et al., 2008, 2009). The geometric mean urinary
Cd/Cr concentrations for all six follow-up examinations in our
study were still higher than the values of 1.8μg g–1 cr for males
and 2.4μg g–1 cr for females found in non-polluted regions of
Japan (Suwazono et al., 2000, 2015). However, this interpretation
is still hypothetical, and further studies should be done.
A comparison of the Cd/Cr concentrations in males and
females (Table 2) showed a clear difference, except for 1986
and 2014. Moreover, the significant correlations between urinary
Cd/Cr and β2-MG/Cr concentrations seen in Table 3 were only
observed in females – there was no clear correlation in males.
This could be explained by menstruation-related anemia or
childbirth. Females commonly exhibit iron deficiency, which
could lead to increased Cd absorption (Peterson et al., 1969;
Nogawa and Ishizaki, 1978). Also, some males may have moved
away to non-Cd-polluted areas to find jobs when they were
younger, thus reducing their exposure to Cd, whereas females
would have remained in the Cd-polluted regions. All these
hypotheses could explain the difference between the correlation
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J. Appl. Toxicol. 2016; 36: 1622–1628 Copyright © 2016 Johnthat the geometric mean Cd/Cr concentration in urine in females
is higher than that in males.
According to the results analyzed in Table 1, the urinary β2-MG/
Cr concentrations fluctuated between 1986 and 1999 and then
increased until 2014 in both males and females. In our previous
study in 1986, 5 years after the end of exposure to Cd, individuals
who had urinary β2-MG/Cr concentrations with over 1000μgg
–1
creatinine in 1981 showed a clear deterioration of β2-MG/Cr in
1986. In contrast, no significant changes in urinary β2-MG/Cr
concentrations were observed in those who had less than
1000μgg–1 creatinine in 1981 (Kido et al., 1988). We also saw that
urinary β2-MG/Cr concentrations fell to less than pH5.5 (Kido et al.,
1985). Furthermore, once renal tubular dysfunction occurs owing
to Cd exposure, metabolic acidosis develops and arterial pH
decreases, whereas urinary pH increases (Kido et al., 1990). We
have, therefore, concluded that the higher urinary β2-MG/Cr
concentration with over 1000μgg–1 creatinine can maintain a
consistently high value, whereas cases of urinary β2-MG/Cr
concentration with less than 1000μgg–1 creatinine are subject to
change depending on the urinary pH. In fact, the geometric
standard deviation (GSD) of urinary β2-MG/Cr in 1999 was greater
than in previous years. However, it is not known why the urinary
pH decreased. Other factors, such as the individual’s overall health
condition or the sampling time, might be worth considering.
Also, the results from Table 5 show us that an increase or
decrease in Cd/Cr concentration does not influence the changes
in β2-MG/Cr concentration observed in this study. Moreover, it is
clear from Table 6 that age is more strongly related to the urinary
β2-MG/Cr concentration found at each health follow-up rather
than the urinary Cd/Cr concentration at the start of the study in
1986. The urinary Cd/Cr concentration in 1986 represents previous
Cd exposure approximately 5 years after Cd pollution was
improved in this region and, as such, exhibits the highest values
of any of the six health follow-ups. Table 6 also illustrates that
age is significantly related with β2-MG/Cr concentration as 2003
in males and 1999 in females. These results, therefore, appear to
indicate that age affects the increase in urinary β2-MG/Cr
concentration much more than recent Cd body burden.Conclusion
Our research is part of a long-term observational study that has
been running for 28 years. In this study, we show that Cd remains
in the human body for more than 30 years after Cd exposure has
ceased and recent urinary Cd concentration increased
significantly. The β2-MG/Cr concentration exhibits an upwards
trend and the significant association between urinary β2-MG/Cr,
and Cd/Cr was observed more clearly in females than in males.
Age affects the urinary β2-MG/Cr concentration much more
strongly than recent Cd exposure. The renal tubular dysfunction
related to Cd exposure is inevitable and worsens. As such, the
monitoring of inhabitants living in Cd-exposed regions is essential.
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